Clinical trial 1301-LG
10-day decitabine versus conventional chemotherapy (?3+7?) followed by allografting in AML patients >= 60 years: a randomized phase III study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group
| Cancers | |
|---|---|
| Organ | Acute leukemia |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2014-001486-27 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02172872 |
| Inclusion criteria | 1st line / >= 60 years old / Eligible for standard intensive chemotherapy/ De novo or secondary AML is allowed |
| Last update |